文献速递浆细胞疾病

骨髓瘤中基因型定义的多克隆浆细胞的异常单细胞表型及临床意义

Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma.
PubMed 文献 · Blood · 2025-01-01

该研究对46例浆细胞疾病患者样本和21例健康供者进行单细胞RNA测序及单细胞B细胞受体分析,在234789个浆细胞中基因型鉴定出64432个多克隆浆细胞。多克隆浆细胞频率随疾病阶段从意义未明单克隆丙种球蛋白病的23.66%降至多发性骨髓瘤的3.23%(P = .00012)。患者多克隆浆细胞显示自噬上调、与肿瘤微环境相互作用破坏及干扰素相关通路富集,并据此构建的健康浆细胞特征可预测CoMMpass数据集中显著更好的无进展生存和总生存(log-rank P < .05)。

要点

  • 多克隆浆细胞频率随疾病阶段从意义未明单克隆丙种球蛋白病的23.66%降至多发性骨髓瘤的3.23%(P = .00012)。
  • 患者多克隆浆细胞干扰素相关通路显著富集(校正P < .05),与健康供者相比显示炎症表型。
  • 基于单细胞RNA测序数据构建的健康浆细胞特征可预测CoMMpass数据集中显著更好的无进展生存和总生存(log-rank P < .05)。

核心结论

  • 浆细胞疾病中基因型单细胞鉴定多克隆浆细胞具有相关的致病和临床意义。

研究设计与样本

  • 对46例浆细胞疾病患者样本和21例健康供者应用单细胞RNA测序和单细胞B细胞受体分析。
  • 共分析234789个浆细胞,其中64432个经基因型鉴定为多克隆浆细胞。

主要发现

  • 多克隆浆细胞频率随疾病阶段从意义未明单克隆丙种球蛋白病的23.66%降至多发性骨髓瘤的3.23%(P = .00012)。
  • 克隆浆细胞和多克隆浆细胞典型谱系标志物CD38和CD138表达相当,而CD27和ITGB7表达更多变。
  • 仅克隆浆细胞过表达癌基因如CCND1/2和NSD2,但CCND3常在多克隆浆细胞中表达。
  • B细胞成熟抗原在多克隆浆细胞和克隆浆细胞上均表达,而GPRC5D主要在克隆浆细胞中上调,对靶向免疫治疗的靶向肿瘤外活性有启示。
  • 与健康供者相比,患者多克隆浆细胞显示自噬上调及与肿瘤微环境相互作用破坏。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple myeloma (MM) is driven by clonal plasma cell (cPC)-intrinsic factors and changes in the tumor microenvironment (TME). To investigate whether residual polyclonal PCs (pPCs) are disrupted, single-cell (sc) RNA sequencing (scRNA-seq) and sc B-cell receptor analysis were applied in a cohort of 46 samples with PC dyscrasias and 21 healthy donors (HDs). Of 234 789 PCs, 64 432 were genotypically identified as pPCs with frequencies decreasing over different disease stages, from 23.66% in monoclonal gammopathy of undetermined significance to 3.23% in MMs (P = .00012). Both cPCs and pPCs had a comparable expression of typical lineage markers (ie, CD38 and CD138), whereas others were more variable (CD27 and ITGB7). Only cPCs overexpressed oncogenes (eg, CCND1/2 and NSD2), but CCND3 was often expressed in pPCs. B-cell maturation antigen was expressed on both pPCs and cPCs, whereas GPRC5D was mostly upregulated in cPCs with implications for on-target, off-tumor activity of targeted immunotherapies. In comparison with HDs, pPCs from patients showed upregulated autophagy and disrupted interaction with TME. Importantly, interferon-related pathways were significantly enriched in pPCs from patients vs HDs (adjusted P < .05) showing an inflamed phenotype affecting genotypically normal PCs. The function of pPCs was consequently affected and correlated with immunoparesis, driven by disrupted cellular interactions with TME. Leveraging our scRNA-seq data, we derived a "healthy PC signature" that could be applied to bulk transcriptomics from the CoMMpass data set and predicted significantly better progression-free survival and overall survival (log-rank P < .05 for both). Our findings show that genotypic sc identification of pPCs in PC dyscrasias has relevant pathogenic and clinical implications.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Da Vià MC, Lazzaroni F, Matera A, et al. Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma. Blood. 2025. PMID: 40009503. doi:10.1182/blood.2024025643

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。